Nabi Biopharmaceuticals (Nasdaq: NABI) has received a $2.5 million payment from Fresenius USA Manufacturing ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE